Dr. Scot C. Callahan, MD

Dr. Callahan practices at Medical Center Enterprise in Enterprise, Alabama, part of Community Health Systems.

Dr. Callahan's NPI, 1023096427, was assigned on January 5, 2006. Dr. Callahan graduated from Wake Forest School of Medicine in 1988. Dr. Callahan's Alabama license number on file is 18006.

Dr. Callahan's primary practice is Medical Center Enterprise, at 400 N Edwards Street, Enterprise, AL 36330 in Coffee County. The practice phone is (334) 347-0584.

Dr. Callahan's primary practice is Medical Center Enterprise in Enterprise, Alabama, part of Community Health Systems. Dmand AI also links Dr. Callahan to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callahan practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Callahan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Callahan is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Callahan's licenses on file in 2 states: Alabama and North Carolina.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Callahan treats.

CMS data shows 2,472 Medicare services from Dr. Callahan across 25 procedure codes in 2024, for 290 Medicare patients. Medicare paid $114,735 for them. Every service was in an office.

CMS counts 290 Medicare patients who saw Dr. Callahan in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Callahan's median patient age at 54, with 49% women.

In 2024, Dr. Callahan wrote 1,694 Medicare Part D claims for 261 patients. 92% of them were for generic drugs. CMS names the drug for 1,509 of them, across 32 drugs with 11 or more claims each, at $160,501 in total drug cost. In 2023, CMS named 1,392 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Callahan for performance year 2024, reported individually. Dr. Callahan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 551 procedures of removal or shaving of skin growth by Dr. Callahan, more than 96% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 162 general payments to Dr. Callahan from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,118.

Dmand AI lists 2 awards for Dr. Callahan, most recently CMS Stage 1 EHR in 2014.

Dr. Callahan graduated from Wake Forest School of Medicine in 1988. Dr. Callahan is a member of American Academy of Otolaryngic Allergy and NHS.

Dr. Callahan is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.